Clinical Trial Update: A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease

View source ↗

Summary

Eli Lilly is sponsoring a clinical trial evaluating retinal imaging to detect abnormal protein deposits linked to Alzheimer's disease, which is currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Eli Lilly and Company | Conditions: Cognitive Dysfunction, Memory Disorders | Status: NOT_YET_RECRUITING